A novel peptide, PLAEIDGIELTY, for the targeting of alpha9beta1-integrins - PubMed (original) (raw)

A novel peptide, PLAEIDGIELTY, for the targeting of alpha9beta1-integrins

H Schneider et al. FEBS Lett. 1998.

Free article

Abstract

Targeting gene therapy vectors to abundant receptors on airway epithelia may allow a significant enhancement of gene delivery and thereby be of particular importance for the gene therapy of cystic fibrosis. Alpha9beta1-integrins are highly expressed throughout the human airway epithelia in vivo, irrespective of any particular clinical status. Aiming to improve the targeting of our non-viral integrin-mediated gene transfer systems to airway epithelia, we searched for a short tenascin C-derived peptide which would bind to these integrins. By utilizing recombinant bacteriophages that display overlapping regions of the third fibronectin type III repeat of tenascin C (TNfn3), we were able to localize its alpha9beta1-integrin binding site to the B-C loop of TNfn3. A synthetic Pro-Leu-Ala-Glu-Ile-Asp-Gly-Ile-Glu-Leu-Thr-Tyr peptide (PLAEIDGIELTY) was shown to displace alpha9beta1-integrin-expressing cells completely from binding to TNfn3. This peptide, therefore, may prove useful both for the examination of the functional importance of alpha9beta1-integrins in vivo and the development of gene therapy vectors or drugs targeting these integrins.

PubMed Disclaimer

Cited by

The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1.
Taooka Y, Chen J, Yednock T, Sheppard D. Taooka Y, et al. J Cell Biol. 1999 Apr 19;145(2):413-20. doi: 10.1083/jcb.145.2.413. J Cell Biol. 1999. PMID: 10209034 Free PMC article.
Peptide-guided gene delivery.
Martin ME, Rice KG. Martin ME, et al. AAPS J. 2007 Feb 9;9(1):E18-29. doi: 10.1208/aapsj0901003. AAPS J. 2007. PMID: 17408236 Free PMC article. Review.
Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.
Fujita M, Sasada M, Iyoda T, Fukai F. Fujita M, et al. Molecules. 2020 Jul 16;25(14):3239. doi: 10.3390/molecules25143239. Molecules. 2020. PMID: 32708610 Free PMC article. Review.
Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
White AF, Mazur M, Sorscher EJ, Zinn KR, Ponnazhagan S. White AF, et al. Hum Gene Ther. 2008 Dec;19(12):1407-14. doi: 10.1089/hum.2008.117. Hum Gene Ther. 2008. PMID: 18778196 Free PMC article.
Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function.
Wiig H, Keskin D, Kalluri R. Wiig H, et al. Matrix Biol. 2010 Oct;29(8):645-56. doi: 10.1016/j.matbio.2010.08.001. Epub 2010 Aug 18. Matrix Biol. 2010. PMID: 20727409 Free PMC article. Review.

A novel peptide, PLAEIDGIELTY, for the targeting of alpha9beta1-integrins - PubMed (original) (raw)